{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:29:33Z","timestamp":1793172573120,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":4789,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.nurt.2010.05.001","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T05:16:52Z","timestamp":1279603012000},"page":"275-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Targeted Treatments for Cognitive and Neurodevelopmental Disorders in Tuberous Sclerosis Complex"],"prefix":"10.1016","volume":"7","author":[{"given":"Petrus J.","family":"de Vries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nurt.2010.05.001_bib1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2010.05.001_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molmed.2007.06.003","article-title":"The tuberous sclerosis complex proteins\u2013a GRIPP on cognition and neurodevelopment","volume":"13","author":"de Vries","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.nurt.2010.05.001_bib3","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/hmg\/6.12.2155","article-title":"Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis","volume":"6","author":"Jones","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2010.05.001_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nurt.2010.05.001_bib5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/088307389801301206","article-title":"Tuberous sclerosis consensus conference: revised diagnostic criteria","volume":"13","author":"Roach","year":"1998","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nurt.2010.05.001_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/cercor\/bhj144","article-title":"Neuroanatomical correlates of memory deficits in tuberous sclerosis complex","volume":"17","author":"Ridler","year":"2007","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.nurt.2010.05.001_bib7","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1017\/S0033291701004561","article-title":"Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis","volume":"31","author":"Ridler","year":"2001","journal-title":"Psychol Med"},{"key":"10.1016\/j.nurt.2010.05.001_bib8","first-page":"75","article-title":"Giant cell astrocytomas in tuberous sclerosis complex","volume":"94","author":"Franz","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nurt.2010.05.001_bib9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2010.05.001_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1167.2009.02341.x","article-title":"Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies","volume":"51","author":"Wong","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.nurt.2010.05.001_bib11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2788.2009.01208.x","article-title":"From mTOR to cognition: molecular and cellular mechanisms of cognitive impairment in tuberous sclerosis","volume":"53","author":"Ehninger","year":"2009","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.nurt.2010.05.001_bib12","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/08830738040190090601","article-title":"Behavioral and cognitive aspects of tuberous sclerosis complex","volume":"19","author":"Prather","year":"2004","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nurt.2010.05.001_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1017\/S0033291702007092","article-title":"Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex","volume":"33","author":"Joinson","year":"2003","journal-title":"Psychol Med"},{"key":"10.1016\/j.nurt.2010.05.001_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMc062928","article-title":"The tuberous sclerosis complex","volume":"356","author":"de Vries","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2010.05.001_bib15","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awf124","article-title":"Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex","volume":"125","author":"Bolton","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2010.05.001_bib16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cell.2008.10.017","article-title":"The autistic neuron: troubled translation?","volume":"135","author":"Kelleher","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.nurt.2010.05.001_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00787-006-0570-3","article-title":"The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families","volume":"16","author":"de Vries","year":"2006","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.nurt.2010.05.001_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jmg.2003.012757","article-title":"Genotype and psychological phenotype in tuberous sclerosis","volume":"41","author":"Lewis","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.nurt.2010.05.001_bib19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jmg.31.10.761","article-title":"Phenotypic variation of tuberous sclerosis in a single extended kindred","volume":"31","author":"Smalley","year":"1994","journal-title":"J Med Genet"},{"key":"10.1016\/j.nurt.2010.05.001_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ajmg.a.32690","article-title":"Neuropsychological attention deficits in tuberous sclerosis complex (TSC)","volume":"149A","author":"de Vries","year":"2009","journal-title":"Am J Med Genet Part A"},{"key":"10.1016\/j.nurt.2010.05.001_bib21","first-page":"836","article-title":"Lateralised spatial attentional bias and white matter tract connectivity in tuberous sclerosis complex (TSC)","volume":"53","author":"McCartney","year":"2009","journal-title":"J Intell Disabil Res"},{"key":"10.1016\/j.nurt.2010.05.001_bib22","first-page":"399","article-title":"Computerized assessment in neuropsychiatry using CANTAB: discussion paper","volume":"85","author":"Sahakian","year":"1992","journal-title":"J Royal Soc Med"},{"key":"10.1016\/j.nurt.2010.05.001_bib23","doi-asserted-by":"crossref","first-page":"R251","DOI":"10.1093\/hmg\/ddi260","article-title":"Tuberous sclerosis: a GAP at the crossroads of multiple signalling pathways","volume":"14","author":"Kwiatkowski","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nurt.2010.05.001_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/BST0370259","article-title":"Therapeutic targeting of mTOR in tuberous sclerosis","volume":"37","author":"Sampson","year":"2009","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.nurt.2010.05.001_bib25","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","article-title":"Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive","volume":"6","author":"Jacinto","year":"2004","journal-title":"Nature Cell Biol"},{"key":"10.1016\/j.nurt.2010.05.001_bib26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol Cell"},{"key":"10.1016\/j.nurt.2010.05.001_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/scisignal.2000803","article-title":"Evolution of the TSC1\/TSC2-TOR signalling pathway","volume":"3","author":"Serfontein","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/j.nurt.2010.05.001_bib28","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/adc.2003.026815","article-title":"The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex","volume":"89","author":"O'Callaghan","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nurt.2010.05.001_bib29","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1017\/S0033291707000177","article-title":"Biological markers of intellectual disability in tuberous sclerosis","volume":"37","author":"Raznahan","year":"2007","journal-title":"Psychol Med"},{"key":"10.1016\/j.nurt.2010.05.001_bib30","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S1734-1140(09)70104-5","article-title":"New indications for antiepileptic drugs application in infants with tuberous sclerosis complex \u2013 prevention of epilepsy","volume":"61","author":"Jozwiak","year":"2009","journal-title":"Pharmacol Reports"},{"key":"10.1016\/j.nurt.2010.05.001_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuron.2008.10.055","article-title":"Translational control of long-lasting synaptic plasticity and memory","volume":"61","author":"Costa-Mattioli","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.nurt.2010.05.001_bib32","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.21317","article-title":"Cognitive deficits in Tsc1+\/\u2212 mice in the absence of cerebral lesions and seizures","volume":"62","author":"Goorden","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2010.05.001_bib33","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.nurt.2010.05.001_bib34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2350-10-88","article-title":"Identification of a region required for TSC1 stability by functional analysis of TSC1 missense mutations found in individuals with tuberous sclerosis complex","volume":"10","author":"Mozzaffari","year":"2009","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.nurt.2010.05.001_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.ejhg.5201276","article-title":"Distinct effects of single amino-acid changes to tuberin on the function of the tuberin-hamartin complex","volume":"13","author":"Nellist","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.nurt.2010.05.001_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.tins.2006.05.010","article-title":"Searching for ways out of the autism maze: genetic, epigenetic and environmental clues","volume":"29","author":"Persico","year":"2006","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.nurt.2010.05.001_bib37","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm0809-850","article-title":"Genetics and neuropsychiatric disorders: genome-wide, yet narrow","volume":"15","author":"de Vries","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.nurt.2010.05.001_bib38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.nurt.2010.05.005","article-title":"Fragile X: leading the way for targeted treatments in autism","volume":"7","author":"Wang","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nurt.2010.05.001_bib39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neuron.2006.03.023","article-title":"PTEN regulates neuronal arborisation and social interaction in mice","volume":"50","author":"Kwon","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.nurt.2010.05.001_bib40","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nurt.2010.05.001_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1203\/01.PDR.0000147727.78571.07","article-title":"Effects of rapamycin in the Eker rat model of tuberous sclerosis complex","volume":"57","author":"Kenerson","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.nurt.2010.05.001_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/gcc.20118","article-title":"Efficacy of a rapamycin analog (CCI-779) and IFN-\u03b3 in tuberous sclerosis mouse models","volume":"42","author":"Lee","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.nurt.2010.05.001_bib43","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2010.05.001_bib44","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1056\/NEJMc072500","article-title":"Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis","volume":"358","author":"Davies","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nurt.2010.05.001_bib45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.2008.08677.x","article-title":"The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis","volume":"159","author":"Hofbauer","year":"2008","journal-title":"B J Dermatol"},{"key":"10.1016\/j.nurt.2010.05.001_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-5945-8-1","article-title":"Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model","volume":"8","author":"Rauktys","year":"2008","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.nurt.2010.05.001_bib47","unstructured":"Krueger DA, Care MM, Agricola K, et al. Safety and efficacy of RAD001 (everolimus) for the treatment of subependymal giant cell astrocytoma in pediatric and adult patients with TSC. Presented at the TSC International Research Conference, University of Sussex; September 11\u201313, 2008; Brighton, UK."},{"key":"10.1016\/j.nurt.2010.05.001_bib48","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2010.05.001_bib49","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signalling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2010.05.001_bib50","unstructured":"Krueger DA, Holland-Bouley K, Byers AW, et al. Effect of RAD001 (everolimus) on epilepsy and neurocognition in patients with TSC. Presented at the TSC International Research Conference, University of Sussex; September 11\u201313, 2008; Brighton, UK."},{"key":"10.1016\/j.nurt.2010.05.001_bib51","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nn1482","article-title":"PI3 kinase signalling is required for retrieval and extinction of contextual memory","volume":"8","author":"Chen","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nurt.2010.05.001_bib52","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1523\/JNEUROSCI.0671-06.2006","article-title":"Spatial memory formation and memory-enhancing effect of glucose involves activation of the tuberous sclerosis complex-mammalian target of rapamycin pathway","volume":"26","author":"Dash","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2010.05.001_bib53","unstructured":"de Vries PJ. The Neuroscience of TSC \u2013 are we at risk of getting lost between the bench and the bedside? Presented at the International TSC Research Conference: From DNA to Human Therapies; September 23\u201326, 2009; Chicago."}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923002180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923002180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurt.2010.05.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:33:58Z","timestamp":1761806038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923002180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1878747923002180"],"URL":"https:\/\/doi.org\/10.1016\/j.nurt.2010.05.001","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted Treatments for Cognitive and Neurodevelopmental Disorders in Tuberous Sclerosis Complex","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurt.2010.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}